At a glance
ClinicalIndex Comparison RecordN/ACompleted· 407 enrolled
Drug / intervention
No Interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Real-world Data of Moderate to Severe Inflammatory Bowel Disease in Brazil: a Non-interventional, Multicenter Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life (RISE BR)
In Brief
An observational study evaluating No Intervention for Inflammatory Bowel Disease. Completed, enrolled 407 participants across 13 sites.
Detailed Summary
The purpose of this study is to gather information regarding the population with moderate to severe inflammatory bowel disease (IBD), the burden of the disease, and understand their treatment patterns, particularly on the use of available biologic therapies.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsInflammatory Bowel Disease
CountriesBrazil
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJul 2016
Enrollment StartOct 2016
Primary CompletionFeb 2018
Study CompletionFeb 2018
TodayJul 2026
First PostedJul 4, 2016
Enrollment StartOct 11, 2016
Primary CompletionFeb 5, 2018
Study CompletionFeb 19, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.0 years ago
Interventions
No Interventionother